Neurogenic inflammation: a study of rat trigeminal ganglion
Open Access
- 8 October 2010
- journal article
- research article
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 11 (6) , 485-495
Abstract
Calcitonin gene-related peptide (CGRP) is linked to neurogenic inflammation and to migraine. Activation of the trigeminovascular system plays a prominent role during migraine attacks with the release of CGRP. The trigeminal ganglion (TG) contains three main cell types: neurons, satellite glial cells (SGC) and Schwann cells; the first two have before been studied in vitro separately. Culture of rat TG provides a method to induce inflammation and the possibility to evaluate the different cell types in the TG simultaneously. We investigated expression levels of various inflammatory cytokines on mRNA level using RT-PCR arrays and qRT-PCR; furthermore expression at protein level was studied using immunohistochemistry. We report that (1) organ culture of the TG is possible with preserved morphology, (2) organ culture is associated with enhanced expression of cytokines and mitogen-activated protein kinases (MAPKs) primarily in neurons, (3) CGRP can induce expression of some cytokines and (4) cytokine expression is still upregulated following MAPK pathway inhibition by MEK inhibitor U0126 and pp38 inhibitor SB202192, but the cytokine expression is abolished when co-incubating with the JNK inhibitor SP600125. This method may be of value to examine local TG inflammation, putatively involved in the pathophysiology of some forms of primary headaches.Keywords
This publication has 32 references indexed in Scilit:
- Epigenetic regulation of the calcitonin gene–related peptide gene in trigeminal gliaCephalalgia, 2011
- Subtype Activation and Interaction of Protein Kinase C and Mitogen-Activated Protein Kinase Controlling Receptor Expression in Cerebral Arteries and Microvessels After Subarachnoid HemorrhageStroke, 2008
- Neuron–Glia Signaling in Trigeminal Ganglion: Implications for Migraine PathologyHeadache: The Journal of Head and Face Pain, 2007
- Targeting MAPK Signalling: Prometheus Fire or Pandoras Box?Current Pharmaceutical Design, 2004
- Stimulation of the Calcitonin Gene-Related Peptide Enhancer by Mitogen-Activated Protein Kinases and Repression by an Antimigraine Drug in Trigeminal Ganglia NeuronsThe Journal of Neuroscience, 2003
- Delayed inflammation in rat meninges: implications for migraine pathophysiologyBrain, 2001
- Tumor Necrosis Factor α Activates the Phosphorylation of ERK, SAPK/JNK, and P38 Kinase in Primary Cultures of NeuronsNeurochemical Research, 2001
- SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytesJournal of Leukocyte Biology, 1998
- Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitroJournal of Neuroscience Research, 1998
- Vasoactive peptide release in the extracerebral circulation of humans during migraine headacheAnnals of Neurology, 1990